Broughton receives Schedule 1 controlled drugs licence

To help category innovators bring novel cannabis and CBD-based medicines and healthcare products to market, scientific testing specialist and consultancy Broughton has received its Schedule 1 Controlled Drugs Licence from the UK Home Office for its Coleby House site in Yorkshire, UK. The licence allows the facility to support cross-site testing with its nearby Oak Tree House facility in Lancashire.

The Schedule 1 Licence means that both of Broughton’s analytical facilities are able to possess and supply cannabis flower oils and finished products. The receipt of Schedule 1 combined with Good Manufacturing Practice (GMP) enables Broughton to perform batch release testing for the medicinal cannabis supply chain.

Broughton’s scientists can conduct analytical testing, perform stability studies, and provide expert toxicology consultancy. These services help manufacturers build the required scientific evidence to support regulatory submissions and ongoing compliance, while ensuring product safety, efficacy, and quality.

“Following huge growth in the cannabinoid market, there is an opportunity for companies to innovate and provide novel healthcare products,” said Chris Allen, Chief Executive Officer at Broughton. “The licence enhances our capabilities as an analytical testing, regulatory consultancy, and innovation partner in this rapidly evolving market, with the ultimate aim of improving people’s quality of life.”

The licence follows a rigorous inspection process from the Home Office’s Drugs and Firearms Licensing Unit. This includes inspection of the facility’s site controls, documentation, standard operation procedures for controlling and handling materials, how materials are tested, and how they are destroyed.

To discuss your project and learn how Broughton can help accelerate your cannabis or CBD product’s journey to market, visit the website.

Ends: 265 words

Image caption:

For further information contact:

Telephone: +44 1282 570524

www: https://www.broughton-group.com/

e-mail: rskelton@broughton-group.com

LinkedIn: https://www.linkedin.com/company/broughton-group/  

Press enquiries: Leah Elston-Thompson

Suites 1 and 2, The Malthouse, Water Street, Stafford, Staffordshire, ST16 1AR
Telephone: +44 (0) 1785 225416

e-mail:  leah@stonejunction.co.uk

www: www.stonejunction.co.uk 

Blog: www.stone-junction.blogspot.com

About Broughton Group: Broughton is an independent life sciences contract research organization serving a global roster of clients from the UK, Europe, North America, the Middle East, Asia, and Australia. We offer high-quality in-house analytical testing services integrated with scientific consultancy and global regulatory support. Our in-house laboratory testing facilities are GMP compliant and ISO/IEC 17025 accredited. We are regularly inspected by the Medicines and Healthcare products Regulatory Agency (MHRA), the US Food and Drug Administration (FDA), and the United Kingdom Accreditation Service (UKAS).

With over 15 years of scientific experience and a world-leading team of scientific and regulatory consultants, we support our partners in bringing innovative products to market to deliver better health outcomes.

Ref: BRO154/04/24